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Abstract
Background: Up to now, costs attributable to adverse events (AEs) and preventable AEs in the
Netherlands were unknown. We assessed the total direct medical costs associated with AEs and
preventable AEs in Dutch hospitals to gain insight in opportunities for cost savings.
Methods: Trained nurses and physicians retrospectively reviewed 7926 patient records in 21
hospitals. Additional patient information of 7889 patients was received from the Dutch registration
of hospital information. Direct medical costs attributable to AEs were assessed by measuring
excess length of stay and additional medical procedures after an AE occurred. Costs were valued
using Dutch standardized cost prices.
Results: The annual direct medical costs in Dutch hospitals were estimated at a total of euro 355
million for all AEs and euro 161 million for preventable AEs in 2004. The total number of hospital
admissions in which a preventable AE occurred was 30,000 (2.3% of all admissions) and more than
300,000 (over 3% of all bed days) bed days were attributable to preventable AEs in 2004. Multilevel
analysis showed that variance in direct medical costs was not determined by differences between
hospitals or hospital departments.
Conclusion: The estimates of the total preventable direct medical costs of AEs indicate that they
form a substantial part (1%) of the expenses of the national health care budget and are of
importance to hospital management. The cost driver of the direct medical costs is the excess length
of stay (including readmissions) in a hospital. Insight in which determinants are associated with high
preventable costs will offer useful information for policymakers and hospital management to
determine starting points for interventions to reduce the costs of preventable AEs.
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Background
Throughout the world health care workers and policy-
makers are trying to improve patient safety. The Dutch
Patient Safety Research Program[1], showed that adverse
events (AEs) affect 5.7% of patients in Dutch hospitals
and lead to permanent disability, morbidity and even
mortality[2]. Forty percent of these AEs were judged pre-
ventable by good clinical practice.
Studies in various countries outside Europe have shown
that AEs in hospitals are associated with high direct med-
ical costs [3-9] which have impact on the annual health
care budget[5,7,9]. These studies showed that the average
excess length of stay (LOS) attributable to AEs ranges from
6 to 8.5 days [3-8] for all AEs. Except for one study[9]
which took place over a decade ago, no data on costs of
preventable AEs are available.
As health care costs are rising hospitals are forced to
reduce costs. Implementation of patient safety improve-
ment interventions in hospitals is often hampered by the
investment costs. Thus insight in costs of preventable AEs
may help to increase the sense of urgency and prioritise
areas to improve patient safety from an economic perspec-
tive in addition to the patient and health care perspective.
In this paper we present the total direct medical costs asso-
ciated with AEs and preventable AEs in Dutch hospitals
with regard to subgroups of university and general hospi-
tals. A separate analysis was focussed on AEs occurring in
patients who died in hospital. The costs were calculated in
two ways, by using the data as determined by the review-
ers and with the use of estimation of expected LOS in hos-
pital based on administrative hospital data. In addition,
we assessed determinants of AE related costs, such as type
of patient admission and AE characteristics, to give insight
in the opportunities for cost savings.
Methods
The instruments of our study were based on the protocol
of the Canadian Adverse Event Study, which was origi-
nally used by the Harvard Medical Practice Study[3,10].
The design and methods of this study have been described
in detail elsewhere[1] a brief summary of the study design
and setting is described below.
Study design and setting
We have performed a retrospective patient record review
study in a random, stratified sample of 21 of the 101
Dutch hospitals: 4 university, 17 tertiary teaching and
general hospitals. To measure the difference in incidence
between hospital types, the sample of hospitals was strat-
ified for hospital type. Proper representation of urban and
rural setting in the sample was verified. Eligible hospitals
had at least 200 beds, an emergency department and an
intensive care unit. A large subsample of deceased hospi-
tal patients was included to determine the occurrence of
potentially preventable deaths in hospitals more precisely
than in previous studies. The power was estimated to
detect a difference in AE rates between different hospital
types. The parameters in the power calculation were based
on the results of the Canadian Adverse Events Study.[3]
Assuming an incidence of AEs of 8%, a sample of 4200
hospital admissions of discharged patients and a sample
of 4200 admissions of deceased patients were necessary (β
= 0.20, α = 0.05) to estimate a 95% confidence interval of
0.5% to both sides.
To measure the difference in incidence between hospital
types a selection of 800 hospital admissions per hospital
type were necessary to detect a difference from 2% to 3%
by an incidence between 3% and 7%. From each hospital,
we randomly selected 200 admissions (> 24 hours stay) of
discharged patients and 200 (or less if the total of patients
who died in 2004 was lower) admissions of deceased hos-
pital patients in 2004, excluding admissions of psychiatry,
obstetrics and children < 1 year old. Ethical approval for
the study was obtained from the Medical Ethical Research
Committee of the VU University Medical Centre.
Study population
The nursing, medical and, if available, out-patient record
of the sampled admissions were reviewed by 66 trained
nurses and 55 trained physicians in a three stage review
process between August 2005 and October 2006. In the
first stage, a nurse screened the records by using 18 screen-
ing criteria indicating potential AEs. The 18 screening cri-
teria were:
1. Unplanned admission before index admission (admis-
sion reasons are related to the index admission)
2. Unplanned readmission after discharge from index
admission
3. Hospital-incurred patient injury (Permanent or tempo-
rary injury obtained (acquired) during index admission)
4. Adverse drug reaction
5. Unplanned transfer from general care to (an) intensive
care (unit)
6. Unplanned transfer to another acute care hospital (after
unexpected deterioration of the patient)
7. Unplanned return to the operating room
8. Unplanned removal, injury or repair of organ during
surgeryBMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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9. Hospital-acquired infection or sepsis
10. Other patient complication
11. Development of neurological deficit not present on
admission
12. Unexpected death
13. Cardiac or respiratory arrest
14. Injury related to abortion or delivery
15. Inappropriate discharge to home
16. Dissatisfaction with care documented in the medical
record
17. Documentation or correspondence indicating litiga-
tion
18. Any other undesirable outcome not covered above
In the second stage, two physicians independently
reviewed the records with one or more positive screening
criteria.
For the analysis on patient record level, patients with
more than one AE during admission, the AE with the most
severe outcome was used for further analysis. Of the initial
8415 sampled records, 8032 were eligible for a first stage
review (screening success rate was 95%). Three-hundred
eighty three records were unavailable or were inadequate
(for example twice sampled or admission was to short). In
the second stage 106 records were excluded during screen-
ing (for example incomplete documentation or hospitali-
sation of the patient during the reviewing process)[2].
Finally, 37 (0.5%) hospital admissions could not be
linked to the Dutch registration of hospital information
(LMR) for linkage to additional information on interven-
tions, due to incorrect unique admission numbers, birth
date or sex. This has resulted in 7889 hospital admissions
present in the data-analysis.
Adverse event assessment
The definition of an AE in our study was threefold: an (1)
unintended (physical and/or mental) injury which results
(2) in temporary or permanent disability, death or pro-
longed hospital stay and (3) is caused by the health care
management rather than the patients' disease[1,11]. A
nurse screened the patient records by using 18 screening
criteria indicating potential AEs. When one or more
screening criteria were found the nurse assigned the
patient record to two physicians of the same specialty
(general surgeons, general internists, neurologists or pae-
diatricians, depending on the main diagnosis of the
admission or age of the patient for the paediatricians)
independently reviewed the patient records using an
extensive standardised review form. Of each AE the
reviewer assessed the impact, location, responsible spe-
cialty, clinical procedure, preventability and causes of the
AE[1]. If there was disagreement about the presence and/
or preventability of an AE between the two independent
physician reviews, they started a consensus procedure. If
they could not reach consensus, a third trained reviewer
gave the final judgement. To determine whether the injury
was caused by health care management and the degree of
preventability of the AE were measured on a 6-point scale.
For AEs a score above three (> management causation
more likely, 50/50 but "close call") were considered an AE
and for an AE to be preventable a score of 4 and higher (>
50%; preventability more than likely) was needed.
Additional administrative hospital information on diag-
nosis (ICD-9-DE), secondary diagnoses, acute or non-
acute admission, main intervention, secondary interven-
tions, expected LOS, and reason for admission were
retrieved for each admission from the LMR maintained by
Prismant.
Cost measurement
The main focus of costs calculated in this study was the
health care sector. Only direct medical costs could be
taken into account due to the nature and design of this
study. Direct medical costs attributable to AEs were
assessed by excess length of stay (LOS) during the index
admission and re-admission, and by additional medical
procedures during the excess LOS as a consequence of the
AE.
Excess LOS during the index admission attributable to AEs
was calculated by taking the average of the two independ-
ent estimates of the physician reviewers and rounded
upwards. The excess LOS was determined based on the
clinical expertise of the physician reviewers. If they were
unable to determine excess LOS, we imputed the excess
LOS based on the LMR, notably the difference between
expected and observed LOS. The estimates varied from no
extra bed days to all bed days of the index admission. For
re-admissions attributable to AEs in the index admission
we imputed the national average hospital stay in 2004
(7.3 days). Additional medical procedures attributable to
AEs were assessed by the physician reviewers, indicating
for each AE whether additional interventions or treatment
were necessary. Additional information on these interven-
tions was added from the administrative hospital data
starting from the date of the AE.BMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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Cost valuation
The excess LOS and the excess medical procedures were
multiplied by unit costs to estimate the total excess direct
medical costs. Dutch guideline prices of 2003 were used
to estimate the costs of one hospital day of standard or
intensive care in a university and general hospital [12-14]
(Table 1). Prices were corrected with price-indices for
2004[13,14]. No unit costs for tertiary medical teaching
hospitals were available; therefore the guideline prices for
general hospitals were used. The unit costs include costs of
a standard hospital day, medical and nursing staff, medi-
cation, material, equipment, housing and overhead. The
costs of procedures and interventions were not included
in these costs. The costs of the excess medical procedures
were estimated by multiplying the number of procedures
by standard price tariffs used for insurance companies,
maintained by the Dutch Healthcare Authority.
Statistical analysis
The national weighted incidence of AEs and preventable
AEs in Dutch hospitals with 95% confidence intervals
(CIs) were calculated, corrected for the overrepresentation
of patients admitted to a university hospital and for the
overrepresentation of patients who died in hospital, using
'complex samples' option in SPSS 15.0. Detailed informa-
tion on the weighing of the sampling frame in order to
gain representativeness for the Dutch population of hos-
pitalised patients and patients which died during hospi-
talisation is described in detail previously. [2]
As the unit price of a hospital day in university hospitals
is higher than in general hospitals, we analysed the costs
attributable to the excess LOS and medical procedures of
AEs separately in both groups. Mean total excess costs per
hospital admission in which an AE occurred was esti-
mated using weights to adjust for the complex sampling
frame. As cost-data were skewed to the right, we used non-
parametric bootstrapping, adjusting for the sampling
frame, to calculate CIs of cost estimates[15]. Non-para-
metric bootstrap is the preferred method to estimate 95%
CIs around cost-estimates because it uses the distribution
of the data rather than assuming a normal distribution.
[16]
Moreover, determinants which may influence the costs
attributable to AEs, such as age, diagnosis, admission
department and medical or surgical responsible specialty,
and type of AEs were first analysed univariate. Average
costs and 95% CIs which were calculated per subgroup
using bootstrapping techniques to resolve the skewed dis-
tribution. In addition, a stepwise multivariate multilevel
analysis, as data were clustered within hospitals and hos-
pital departments, was used to study the relation of these
determinants with the costs of AEs and to test our univar-
iate associations. Within all steps of the multivariate mul-
tilevel analysis, data were adjusted by a normalisation
procedure for the overrepresentation of university hospi-
tals and deceased patients. The dependent variable in the
model was either the costs of AEs or the excess LOS (based
on the LMR). Independent variables added to the model
were successively age, sex, admission type (urgent or elec-
tive), main diagnosis groups (ICD9-DE), Charlson
comorbidity index and surgical or non-surgical admission
department. The amount of variation in costs of AEs
caused by the hospital level or hospital department level
was expressed by the intraclass coefficient (ICC).
The national estimate of costs attributable to AEs in 2004
was calculated by multiplying the total amount of Dutch
hospital admissions with the AE rate and by subsequently
multiplying this with the average costs. The same was
done for costs attributable to preventable AEs.
SPSS for Windows version 15.0 was used for most statisti-
cal analyses, only the multivariate multilevel analyses
were performed using MLwiN version 2.0.
Sensitivity analysis
As it is sometimes difficult to determine the excess LOS
due to the AE based on record review, we used a different
approach in calculating excess LOS. For each individual
admission in our sample we obtained the expected LOS
from the LMR. Within the LMR, for each hospital admis-
sion, the expected LOS is calculated based on the follow-
ing characteristics of the patient and the national mean
length of stay that is associated with these characteris-
tics[7]. The characteristics that have been taken into
account were:
• Age, divided in 5 classes (0, 1–14, 15–44, 45–64, 65+
years);
￿ Primary diagnosis. (it included about 1,000 diagnoses
classified by the ICD9-CM in three digits);
￿ Procedures, classified by the Dutch Classification Sys-
tem of Procedures (procedures depend on the diagnosis of
the patient. It included five procedure groups)
Table 1: Hospital day unit prices 2004
In euro (corrected for 2004)
Academic hospital day 481,63
General hospital day* 340,99
Intensive care day* 1703,92
* From an economic perspective the costs of tertiary teaching 
hospitals are the same as general hospitals. Intensive care days are 
only overall available.
Source: Oostenbrink JB, et al. 2004.BMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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Together these three parameters produced about 5 * 1,000
* 5 = 25,000 possibilities of expected LOS. Normally these
calculations were only used for patients discharged alive,
but for the purpose of this study the expected LOS was
also calculated for the patients which died in hospital.[17]
Excess LOS was calculated as the difference between the
expected and the observed LOS.
Results
Population
In total 7926 patient records have been reviewed by
nurses and physicians. Additional information from the
LMR could not be acquired for 37 patients due to record
linkage problems. The missing patients were randomly
divided over the 21 hospitals. The study population for
the following results consisted of 7889 hospital admis-
sions. Characteristics of the 7889 admissions are shown in
table 2.
In the 7926 patient records the nurses found one or more
screening criteria in 54% of the nursing and medical
records. In the second stage the physician reviewers found
774 AEs in 663 hospital admissions. Within these admis-
sions the 663 patients suffered from one or more AE, com-
prising 216 discharged and 447 patients which died
during hospitalisation. The 37 hospital admissions that
could not be linked contained no AEs.
Length of stay
Excess LOS attributable to the AE could be estimated by
the physicians in 96% of the cases. In the other cases we
imputed the excess LOS based on the data from the LMR.
In 22% of the AEs the physician reviewers indicated that
the admission itself was caused by the AE, thus the AE
occurred in a previous admission but was detected in or
was the reason for the index admission. On average, the
excess LOS due to the AEs was 10.1 days (95% CI: 6.4 –
11.9) for university hospitals and 8.9 days (95% CI: 6.9 –
9.6) for general hospitals (Table 3). This difference was
not statistically significant.
Medical procedures
The medical procedures attributable to AEs, mainly re-
operations, accounted for approximately 15% of the med-
ical costs attributable to AEs (Table 3). Non-invasive pro-
cedures (for example casting a leg, pulmonary function
tests or X-thorax) were almost never recorded in the regis-
tration of hospital information. The registration of medi-
cal procedures other than surgical procedures in the
registration of hospital information was poor in both uni-
versity and general hospitals. Consequently, the estimated
costs of medical procedures are an underestimation of the
real costs.
Costs of (preventable) AEs
Although the number of preventable AEs in university
hospitals was lower than in general hospitals[2], the total
costs rose substantially when the AE was reviewed as pre-
ventable (Table 3). This result however was not statisti-
cally significant.
Determinants of costs of (preventable) AEs
The excess LOS (5.6 days to 16.8 days) and consequently
the excess costs (€2979 to €6649) of preventable AEs
increased when the impairment or disability was more
severe (Table 4). In hospital deaths, in which readmis-
Table 2: Comparison of patients with LMR data and all patients reviewed
Patient data Total sample reviewed* Total sample deceased patients**
Number of inpatient admissions 7889 3959
Number of admissions in university hospitals 1378 780
Mean age in years (sd) 57.5 (21.5) 73.0 (13.4)
Sex (% male) 49.0 53.8
Admission in days mean (SD/median) 8.5 (10.5/5.0) 12.4 (14.3/7.0)
Urgent admissions (%) 53.6 87.0
Admission department in %:
Surgery 24.1 11.7
Cardiology 12.9 13.0
Internal medicine 15.8 30.2
Orthopaedics 10.4 1.7
Neurology 7.5 12.3
Pulmonary disease 7.2 13.1
Ear, nose and throat 4.3 0.4
Urology 4.2 1.2
Other 13.6 16.4
* Psychiatric and obstetric patients and patients < 1 year were excluded. Day admissions were only excluded in the discharged patients. Figures 
were weighted for oversampling of deceased patients and of patients admitted to a university hospital.
** Psychiatric and obstetric patients and patients < 1 year were excluded. Figures were weighted for oversampling of deceased patients admitted to 
a university hospital.BMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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sions were impossible, the average costs of AEs were
somewhat lower than in discharged patients. Surgical AEs
resulted in longer excess LOS and thus higher excess costs
than non-surgical AEs. Internal medicine en neurology
costs increased when the AE was preventable, costs and
excess LOS of the preventable AEs in orthopaedics
decreased. With respect to the types of AEs, the surgical
and medication related AEs were the most expensive. The
relative importance of subgroups changed when adding
the costs to the distribution. For example the impact of the
age group 65–79 changed from 32% by just looking at
AEs to 57% by combining preventable AEs and costs of
preventable AEs and the preventable AEs with an intensive
care admission only contributed to 3% of all preventable
AEs, while the costs as a result of these preventable AEs
resulted in almost 30% of all preventable AE costs.
The multivariate multilevel analysis showed that the
height of the costs attributable to AEs was statistically sig-
nificant higher for patients with a higher age, surgical
patients compared to non-surgical patients, and several
diagnostic groups (table 5). After adding the diagnostic
groups to the model and after correction for the previous
added variables AEs in patients with neoplasms were
more expensive followed by circulatory diseases, respira-
tory diseases, diseases of the digestive system, symptoms,
signs and ill-defined diseases and injury and poisoning.
Variation at hospital and hospital department level
showed little influence on variance of costs, respectively
ICC = 0.006 and ICC = 0.008.
Extrapolation
The excess LOS attributable to preventable AEs (10.3
days) was higher than the mean duration of a hospital
stay in 2004 (7.3 days). Extrapolating these figures results
in an estimate of 31,164 hospital admissions in which a
preventable AE occurred or the entire admissions was
caused by an AE and in 320,680 bed days attributable to
preventable AEs in the Netherlands in 2004.
Medical costs attributable to AEs during hospitals admis-
sions in 2004 were more than € 355 million (95% CI:
€316 million – €398 million) for all AEs and more than
€161 million (95% CI: €134 million – €195 million) for
preventable AEs. The national health care budget in 2004
was €14.5 billion therefore all AEs resulted in 2.4% and
preventable AEs 1.1% of the national health care budget.
Sensitivity analysis of costs of AEs
In the sensitivity analysis the excess LOS is calculated by
subtracting the observed LOS with the expected LOS
based on national reference values. The analysis of
observed LOS and expected LOS showed a lower, but
trend wise similar, result as the analysis based on review-
ers excess LOS. The mean excess LOS was 5.9 days and the
total costs of AEs (including readmissions and proce-
dures) €4,446 per AE. The mean excess LOS of preventa-
ble AEs was 4.4 days and the total costs €3,634 per
preventable AE. Within admissions without AEs the
observed LOS was slightly lower, patients are on average
0.5 days shorter in hospital than expected.
Table 3: Excess length of stay and mean costs of AEs for (potentially preventable) adverse events in the Netherlands in 2004
Mean excess LOS in 
days (95% CI)
Mean costs of LOS in € 
(95% CI)
Mean costs of medical 
procedures in € (95% CI)
Mean total costs of AEs 
in € (95% CI)
All AEs*
(n = 456)
9.1 (7.6 – 10.5) 3852 (3081 – 5009) 703 (452 – 923) 4555 (3694 – 5790)
Deceased patients** 6.3 (5.3 – 8.3) 3962 (2582 – 4179) 524 (366 – 704) 4487(3065 – 4784)
University hospitals*** 10.1 (6.4 – 11.9) 5298 (3580 – 7943) 189 (53 – 282) 5487 (3673 – 8075)
General hospitals*** 8.9 (6.9 – 9.6) 3543 (2695 – 4273) 813 (556 – 969) 4356 (3357 – 5062)
All preventable AEs*
(n = 182)
10.3 (7.8 – 13.2) 4778 (3081 – 7066) 507 (309 – 850) 5286 (3470 – 7786)
Deceased patients** 6.5 (4.4 – 9.7) 3763 (2266 – 4778) 765 (338 – 952) 4528 (2830 – 5370)
University hospitals*** 15.7 (8 – 21) 8054 (5041 – 11834) 45 (0 – 173) 8100 (5144 – 11944)
General hospitals*** 9.7 (7.4 – 13.2) 4436 (2609 – 7396) 556 (323 – 931) 4992 (3033 – 8188)
* Psychiatric and obstetric patients and patients < 1 year were excluded. Day admissions were only excluded in the discharged patients. Figures 
were weighted for over sampling of deceased patients and of patients admitted to a university hospital.
** Subgroup analysis, sample is not weighted for overrepresentation of deceased patients in the sample.
*** Psychiatric and obstetric patients and patients < 1 year were excluded. Day admissions were only excluded in the discharged patients. Figures 
were weighted for over sampling of deceased patients.BMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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Table 4: Univariate estimation of excess length of stay and excess costs (in Euro) of adverse events
Cost categories All Adverse events* (n = 663, weighted n = 456) Preventable Adverse events* (n = 283, weighted n = 182)
Disability** N Mean days (se) Cost in € including interventions 
(se)
N Mean volume (se) Cost in € (se)
No disability 115 5.5 (1.0) 2970 (475) 29 5.6 (1.7) 2979 (781)
Minor disability 276 10.4 (0.7) 5174 (598) 117 11.2 (1.2) 5973 (1332)
Permanent disability 21 16.0 (3.1) 6232 (1331) 16 16.8 (3.9) 6649 (1667)
Deceased 35 7.8 (2.8) 4566 (1636) 17 7.0 (5.0) 3831 (2263)
Speciality
Surgical 293 10.1 (0.7) 5474 (601) 115 10.7 (1.3) 6122 (1371)
Medical 163 7.4 (0.8) 2909 (339) 66 9.7 (1.6) 3831 (654)
Type of hospital
Academic 80 10.1 (1.5) 5488 (858) 17 15.7 (3.3) 8100 (1515)
General hospitals 376 8.9 (0.6) 4356 (460) 165 9.7 (1.1) 4992 (985)
Age categories
1–18 years 10 1.4 (0.4) 597 (127) 2 0 (0) 0 (0)
19–40 years 54 12.2 (1.9) 5303 (854) 22 12.3 (3.3) 4727 (1280)
41–65 years 161 7.1 (0.8) 3736 (379) 61 8.2 (1.5) 3652 (537)
66–79 years 139 11.9 (1.2) 6413 (1170) 55 14.8 (2.2) 9290 (2770)
80 years and over 91 7.5 (1.0) 3134 (407) 42 6.9 (1.5) 2923 (700)
ICD9DE primary groups***
Neoplasms 52 8.8 (2.1) 7636 (2923) 13 14.4 (6.8) 18734 (10772)
Circulatory system 86 7.5 (1.0) 4396 (608) 26 10.7 (2.2) 4542 (853)
Respiratory system 31 6.1 (1.7) 2519 (751) 18 7.0 (2.8) 2938 (1235)
Digestive system 45 10.4 (1.9) 4789 (951) 20 9.3 (3.3) 3963 (1179)
Genitourinary system 35 8.5 (1.3) 4068 (916) 13 13.7 (2.7) 6640 (2250)
Muscoskeletal system and connective 
tissue
41 7.4 (1.6) 3093 (553) 16 3.1 (0.7) 1601 (330)
Symptoms, signs, and ill-defined 
conditions
33 7.8 (1.4) 2834 (484) 13 11.1 (2.8) 3831 (981)
Injury and poisoning 69 14.4 (1.8) 6084 (781) 31 14.2 (2.9) 5976 (1172)
Admission departments***
Cardiology 54 8.8 (1.7) 3852 (766) 18 9.7 (2.2) 3685 (787)
Surgery 146 10.7 (1.0) 5443 (455) 59 12.2 (2.0) 4962 (746)
Intensive Care 10 16.0 (7.8) 29307 (14313) 5 28.3 (13.7) 52058 (25329)
Internal Medicine 68 8.8 (1.5) 3423 (595) 15 13.4 (4.7) 5451 (1906)
Pulmonary diseases 31 7.9 (2.6) 3137(955) 22 7.7 (3.5) 3010 (1251)
Neurology 21 7.3 (2.3) 2700 (1002) 13 10.8 (3.5) 4057 (1572)
Orthopaedic 42 9.0 (1.5) 3739 (532) 22 4.4 (0.8) 2362 (317)
Urology 26 9.5 (1.0) 3854 (375) 8 11.3 (1.6) 4336 (703)
Type of AE
Diagnostics 29 12.0 (2.8) 4812 (1250) 24 13.4 (3.2) 5433 (1444)
Surgical 249 10.3 (0.8) 5764 (695) 84 10.8 (1.7) 6735 (1854)
Intervention (non surgical) 81 6.0 (0.8) 2414 (337) 26 9.6 (1.9) 3454 (706)
Medication 66 8.1 (1.4) 3105 (579) 21 9.2 (2.9) 3992 (1309)
Other clinical activities 16 5.1 (1.6) 2438 (757) 13 6.0 (1.8) 2832 (856)
Discharge 6 18.5 (6.9) 6856 (2477) 6 18.5 (6.9) 6856 (2478)
Other 11 5.2 (2.0) 2828 (1545) 9 2.9 (1.6) 2131 (1740)
* Figures were weighted for oversampling of deceased patients and of patients admitted to a university hospital.
** Unable to determine in 9 and 3 patients in respectively all AEs and preventable AEs
*** Largest ICD-9-DE groups onlyBMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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Discussion
Extrapolation of the results of this study showed that the
total potentially preventable direct medical costs of AEs in
Dutch hospitals are more than €161 million in Dutch
hospitals in 2004; this is approximately 1% of the annual
hospital budget of €14.5 billion. [18] The cost driver of
the direct medical costs is the excess LOS in the hospital.
Unit price of ICU stay, surgical AEs and age influence the
impact of the direct medical costs in addition to incidence
of AEs alone. We have also seen that, although it is often
assumed that patients who die, whether or not related to
an AE, have no or low excess costs, our study showed that
the excess costs related to (preventable) AEs in patients
who die in hospital are still substantial both for excess
LOS and extra interventions. When disregarding the
readmissions of the discharged patients, the excess LOS
related to the AE was almost as high for deceased com-
pared to discharged patients (6.3 days and 7.4 days
respectively). These results are in concordance with the
results of the cost of illness studies preformed in the Neth-
erlands. Health care costs are ten-times more expensive in
the year before death but decline when people die at older
age[19].
There are several reasons to assume that our cost estima-
tion is conservative. Firstly, other research has shown that
due to inefficiencies after things go wrong, the average
costs of a hospital day becomes more expensive after an
AE[20]. We used the same guideline unit price of a hospi-
talisation day before and after an AE. Secondly, non-inva-
sive procedures are underreported in the LMR, where
surgical interventions are registered well. Since non-inva-
sive procedures are no cost-drivers, we do not expect this
has led to major distortion of our results. Thirdly, as some
AEs do not become apparent until after the selected
admission, we also took into account the hospitalisation
after the selected admission when related to the AE. When
the physicians reported a hospitalisation after the index
admission they did not record the number of readmis-
sions and the number of days of each readmission. There-
fore only one readmission was added to the excess LOS
with an average LOS according to the Dutch reference val-
ues (7.3 days in 2004). Fourth, due to the retrospective
study design and use of administrative information, the
information of each admission may not have been com-
plete. As a result the reviewers of the patient records may
have missed some relevant data. Consequently, our esti-
mate might be an underestimation of the total direct med-
ical costs of AEs. However, knowing the outcome and its
severity may influence judgment of the AE and the excess
LOS. Thus, the possibility to reduce costs as a result of pre-
ventable AEs may have been overestimated by retrospec-
tive analysis of the AEs[21].
Although it is sometimes difficult to attribute the excess
LOS or the additional procedures to the AE, the two
approaches we used to calculate the total expenses
showed similar results. Where the excess LOS based on the
reviewers viewpoint may be an overestimation of the true
excess LOS, the difference between the expected and
observed LOS based on the LMR data may be an underes-
timation. The expected LOS is an estimation based on
Table 5: Results of the multivariate multilevel analysis of the costs of AEs with clustering on hospital level and hospital department 
level
All adverse events
β
Preventable adverse events
β
Intercept 366 289
Adverse event 4516 3521
Age -11.2 * -9.6 *
Sex -3.3 -7.5
Admission type -341 -506
Diagnostic groups (ICD9DE)
Endocrine, nutritional and metabolic diseases, and immunity disorders -584 -568
Nervous system and sense organs -474 -531
Circulatory system -1735 * -1727 *
Respiratory system -1334 * -1346 *
Digestive system -1049 * -986 *
Genitourinary system -606 -608
Symptoms, signs and ill-defined conditions -872 * -909 *
Injury and poisoning -1283 * -1162 *
All other codes -896 * -898 *
Charlson index -81 -81
Speciality -676 * -606 *
Dependent variable: costs of admission. Independent variables: age: continuous variable, sex: male as reference, admission type: non urgent as 
reference, diagnostic groups: neoplasms as reference, Charlson comorbidity index: continuous variable, speciality: non-surgical as referenceBMC Health Services Research 2009, 9:27 http://www.biomedcentral.com/1472-6963/9/27
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yearly data including admissions with AEs. The use of
observed LOS minus the expected LOS may lead to an
underestimation of the excess LOS. Nevertheless, despite
these limitations, excess LOS gives a useful estimate of the
direct medical costs associated with AEs and the potential
cost savings of preventable AEs. Moreover because the
admissions without an AE show on average no excess LOS
(half a day shorter than expected). Patients with an AE
stayed in hospital on average 4.6 more days than
expected. The LMR is not an economic database, but an
administrative database, so there are reasons to assume
registration bias. Nevertheless, results of internal valida-
tion of our data showed that the registered information in
the LMR provided by the hospitals was in good accord-
ance with the information from the patient records. With
respect to the most important data such as LOS, admis-
sion department and main diagnosis the results were
good.
We used price indices appropriate for cost estimates deter-
mined from a societal perspective although the perspec-
tive of our study was focussed on the hospital. Since there
were no cost estimates available from a hospital perspec-
tive and the most important elements are included in the
standard unit price of a hospital day[13], we do not
assume that a different perspective would have led to dif-
ferent results.
A recent study has shown that yearly €85 million of
health care costs were caused by potentially preventable
hospital admissions related to medication related adverse
events in outpatient care[22]. As our study only focuses on
the AEs during or caused by hospitalisation, the results of
that study can be added to our results when looking at
patient safety issues in the Netherlands.
Our study only focuses on the direct medical costs of AEs
in hospital. From a societal perspective outpatient health
care, loss of income and premature death are also impor-
tant and the estimation of costs related to AEs would have
been higher when estimated from a societal perspective.
Although judgement of presence of AEs is difficult, retro-
spective patient record studies currently offer the best
method available to assess incidence of AEs[23]. By mak-
ing use of the three stage AE determination method, the
representative sample of both hospitals and number of
patient records our study produced the needed insight in
the present state of patient safety in hospitals[1]. Moreo-
ver, the additional information from each hospital admis-
sion from the LMR gave us an opportunity to ground our
results.
Conclusion
The estimates of the total potentially preventable direct
medical costs of AEs indicate that they form approxi-
mately 1% of the expenses of the national health care
budget. The cost driver of the direct medical costs is the
excess LOS in the hospital.
Despite the limitations by retrospective analysis of AEs,
the costs of AEs in the Netherlands, estimated in this study
are high and show that improvement of patient safety by
preventing AEs may be cost saving. If the financial system
is such that the hospital or hospital department profits of
this cost reduction, it may offer an economic incentive to
invest in patient safety. Insight in the determinants of
potentially preventable AEs offers a starting points for
patient safety interventions.
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